Purchases and Sales Made in Q2 2024 in Effector Therapeutics Inc (EFTRW)
This table provides information about the institutional ownership of Effector Therapeutics Inc (EFTRW) during Q2 2024. The information is specifically focused on institutions that hold shares of EFFECTOR THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
184K+ 1094.22% |
$0 - $29.4K
|
201K
$0
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
BUY
|
- |
63K+ 9782.76% |
$0 - $10.1K
|
63.6K
$0
|
|
|
Aug 01, 2024
Q2 2024
|
Wolverine Asset Management LLC
|
BUY
|
- |
8.41K+ 85.56% |
$0 - $1.35K
|
18.2K
$0
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q2 2024
|
Iii Capital Management
Boca Raton, FL |
SELL
|
- |
-5.22K- 12.48% |
$0 - $835
|
36.6K
$0
|
|
|
Aug 14, 2024
Q2 2024
|
Aristeia Capital LLC
Greenwich, CT |
SELL
|
- |
-29.8K- 2.23% |
$0 - $4.77K
|
1.3M
$0
|